Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
Clinical trial NCT02213107 · COMPLETED
Trial details
- NCT number
- NCT02213107
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2023-10-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.